The RAMP platform is a global leader in acute care diagnostic testing for triage directly from whole blood samples. We understand the stresses associated with rapid and accurate diagnosis when every minute counts. We are committed to providing lab-quality results within minutes that medical teams can trust, while reducing the total cost of care.
Response is focused on enabling our strong network of partners to be leaders in their markets by providing high quality diagnostic tests and exceptional levels of support. Response fosters a values-based culture, and we believe the people we work with internally and externally are the cornerstone of our success. Response has a world-class R&D and manufacturing facility in beautiful Vancouver, Canada and our Quality Management System (QMS) is ISO 13485:2016 and MDSAP certified by Intertek.
We commit to responding to any request within 24 hours, or else we will pay you $500. This commitment reflects our unwavering passion and dedication to providing the best customer experience around the clock. Reach out to us through our 24/7 Response support line at 1-866-525-7267. Our dedicated team is always available to answer any questions or concerns.
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
“Our team at Response is passionate about improving the lives of patients and their families around the world through providing accurate diagnostic test results. We are a diverse team of people originating from over 20 countries which is a key differentiator in driving our global growth strategy.” Proven CEO and industry expert Dr. Barb Kinnaird helps companies bridge the gap between innovation and profitability. With over 20 years in leadership roles primarily in the field of point of care diagnostics, Dr. Kinnaird is passionate about guiding leaders through transitions by focusing on organizational mindsets and their products to elevate and grow company value. Dr. Kinnaird has served as Chief Executive Officer of Response Biomedical Corporation since 2015. Through her leadership, Response Biomedical has transformed and expanded from a niche market into a global acute care diagnostics leader, expanding product availability worldwide to improve patient outcomes and support decentralization of diagnostic testing. A patent-holder and author of numerous academic publications, Dr. Kinnaird is an active leader in the global medical diagnostic community and a sought-after mentor to fellow CEOs. Barb holds a Level 2 certification from the Innovation Governance Program (iGP), a cutting-edge Board Governance program. Since 2019, she has served as a Director on the Board of Acetech, a Canadian non-profit organization designed by CEOs to help CEOs grow and scale tech businesses and stimulate the economy through job creation and global expansion. Dr. Kinnaird holds a Ph.D. in Microbiology and Immunology from the University of British Columbia. She conducted her post-doctoral research at the Michael Smith Laboratories in genomics and gene expression profiling, in collaboration with the B.C. Genome Sciences Centre while acting as a consultant for the Proteomics division of Incyte Genomics Inc. She continues to share her expertise in life sciences as an Advisor to Genome BC and Global Affairs Canada.
